Heregulin-induced AKT activation promotes growth of gefitinib ('Iressa', ZD1839)-treated, tamoxifen-resistant breast cancer cells [Abstract]

Hutcheson, Iain Robert, Knowlden, Janice Mary, Barrow, Denise, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Robertson, J. F., Wakeling, A. E. and Nicholson, Robert Ian 2003. Heregulin-induced AKT activation promotes growth of gefitinib ('Iressa', ZD1839)-treated, tamoxifen-resistant breast cancer cells [Abstract]. Breast Cancer Research and Treatment 82 (S1) , S170. 10.1023/A:1026252325164

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Pharmacy Medicine
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) R Medicine > RM Therapeutics. Pharmacology
Additional Information:	Abstract for 26th Annual San Antonio Breast Cancer Symposium
Publisher:	Springer Verlag
ISSN:	0167-6806
Last Modified:	18 Oct 2022 14:20
URI:	https://orca.cardiff.ac.uk/id/eprint/17187

Actions (repository staff only)

Edit Item